See what others are discussing and join the conversation.
Giredestrant Promising New Treatment For Early-Stage HR-Positive Breast Cancer December 10, 2025 After surgery, many people with stage I to stage III hormone receptor-positive breast cancer take tamoxifen or an aromatase inhibitor for five to 10 years. This has been the standard of care for the last 25 years. At the 2025…
Imlunestrant is a hormonal therapy medicine used to treat advanced-stage hormone receptor-positive breast cancer that grew during treatment with other hormonal therapy medicines. Read our breaking news article.
Testing for ESR1 Mutations, Then Switching to Camizestrant Improves Outcomes for Metastatic HR+ HER2- Breast Cancer May 31, 2025 After two years of follow-up, the new treatment improved survival and quality of life. Read more…
New Hormonal Therapy Vepdegestrant Promising for Some Metastatic HR+ Breast Cancers May 30, 2025 The new medicine offered more benefits than Faslodex. Read more…
Hello, I'm 48 and I was recently diagnosed with Invasive Lobular cancer of my left breast after a long journey. It started in December of 2023 when on a MRI they saw a spot that they wanted to recheck in six months. I was not super concerned as this had happened before on the right-hand side and it turned out to be…
https://www.breastcancer.org/treatment/targeted-therapy/dato-dxd
Diagnosed with DCIS (ER+/PR+) in Sept. Had it removed in Oct. Doc talked abt possible radiation and/or hormones even though I'm one of the "lucky" ones- HA! Now I'm positive for CHEK2 and RAD51C w a family history of ovarian and colon cancer (1 + 1). Waiting to hear back from gyn to screen for ovarian cx and sons need to…
Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer Dec 12, 2024 Dr. Aditya Bardia discusses Enhertu for metastatic hormone receptor-positive, HER2-low and -ultralow breast cancer and explains those terms. At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program…
I was just diagnosed and am deciding between treatment options. I am already scheduled for surgery but now I am having doubts about the Lumpectomy and subsequent radiation therapy. In my honest opinion, I now feel that the mastectomy could be the better choice due to avoiding the radiotherapy and hormone therapy. Feeling…
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation? Dec 6, 2023 Research suggests that some younger post-menopausal women may be able to skip radiation after lumpectomy, but there are important points to consider. Read more…
ART Doesn’t Increase Hormone Receptor-Positive Breast Cancer Recurrence Risk Dec 7, 2023 Dr. Hatem Azim explains his new analysis of data from the POSITIVE trial. At the 2023 San Antonio Breast Cancer Symposium, Dr. Hatem Azim presented a new analysis of information from the POSITIVE trial, which found that younger women…
https://www.breastcancer.org/research-news/chek2-mutations-treatment-resistance
https://www.breastcancer.org/research-news/black-women-oncotype-less-accurate
It looks like you're new here. Sign in or register to get started.
These posts are awaiting responses - can you help?
Community Director Melissa Jenkins offers perspective on learning to trust your body again after a breast cancer diagnosis.
Community Director Melissa Jenkins shares tips on how to navigate the special occasions in life that can feel heavy when you’re managing breast cancer.
Community Director Melissa Jenkins shares ways to talk with loved ones about what’s important to you when you’re living with metastatic breast cancer.
Browse our Breastcancer.org merchandise
We'd love to hear it.